Latitude Horizon Fund


THE OBJECTIVE OF THE LATITUDE HORIZON FUND IS TO DELIVER CAPITAL APPRECIATION OVER THE LONG TERM BY HOLDING A CONCENTRATED PORTFOLIO OF STOCKS, WHILST LOWERING THE EQUITY RISK THROUGH A SELECTION OF NON-EQUITY INVESTMENTS. 

May 2019 Commentary

Imperial Brands has been a detractor from performance since we launched, despite reasonable underlying operating trends. With mature businesses like Imperial, the most important consideration is the ability of the business to generate cash. This can be used either to invest or, more likely, to return to shareholders justifying the decision to own shares in a mature franchise. We also look for under-appreciated optionality which if realised, will lead to better than expected growth and a stock re-rating. We believe that Imperial possesses both these attributes.

Critically, the business can continue to generate healthy cash flow. The tobacco industry has enviable characteristics: it is a consolidated six player market with barriers to entry, principally regulation and scale. Size matters for purchasing, manufacturing, and distribution as well as a company's capacity to respond to regulatory demands. This size advantage reasons the marked absence of smaller players and private label alternatives. Consequently, incumbents operate in a formidably strong and rational pricing environment with a 'tax shield' of more than 70%. This shield enables big price increases with only a small change to cost for the consumer. For Imperial, this innate pricing power combined with a limited fixed cost base means that even with declining volumes, the business is still able to generate healthy operating profit and cash conversion in excess of 95%. This annuity-like cash flow underpins the dividend.

The optionality in Imperial is two-fold - a portfolio rationalisation programme and its NGP (Next Generation Product) business. For the past two years management have been reducing the number of brands in the portfolio and focusing capital investment on higher return and growth markets. We are seeing the fruits of this programme with reported volumes outperforming its underlying markets. The CEO has also outlined a £2bn disposal opportunity. Once these proceeds are realised, the company's net debt position will improve considerably.

By the end of this year, Imperial will have more than £400m of sales in NGP products - namely myBlu, the company's vaping product, currently growing more than 200% annually. Despite the headlines around the popularity of the market leader Juul, the industry is still in its infancy and represents an exciting growth opportunity with room for many players. Imperial has assembled a strong team around its NGP initiative and the company is very well positioned to grow this part of its business. NGP's could generate profit of £400-450m by 2021 equating to 10% of company profits v 0% today.

Management’s long term incentive plan is telling of internal optimism with a target of 4-10% top line growth over the next three years. Achieving just the lower end of this range would still result in a material uptick to market expectations. Meanwhile the stock is attractively valued, trading on a 11% dividend yield and less than 7x next year's earnings. At this valuation, the market is suggesting the business will shrink whereas we see prospects for future growth. We are happy to be patient, collect the dividend and use the stock as a welcomed diversifier within the portfolio.

Fact Sheet
May 2019 Factsheet

May 2019 Factsheet

April 2019 Factsheet

April 2019 Factsheet

March 2019 Factsheet

March 2019 Factsheet

February 2019 Factsheet

February 2019 Factsheet

January 2019 Factsheet

January 2019 Factsheet

 

2018 Factsheets

December 2018 Factsheet

December 2018 Factsheet

November 2018 Factsheet

November 2018 Factsheet

October 2018 Factsheet

October 2018 Factsheet

September 2018 Factsheet

September 2018 Factsheet

August 2018 Factsheet

August 2018 Factsheet

July 2018 Factsheet

July 2018 Factsheet

June 2018 Factsheet

June 2018 Factsheet

May 2018 Factsheet

May 2018 Factsheet

April 2018 Factsheet

April 2018 Factsheet

March 2018 Factsheet

March 2018 Factsheet

February 2018 Factsheet

February 2018 Factsheet

January 2018 Factsheet

January 2018 Factsheet


2017 Factsheets

December 2017 Factsheet

December 2017 Factsheet

November 2017 Factsheet

November 2017 Factsheet

October 2017 Factsheet

October 2017 Factsheet

September 2017 Factsheet

September 2017 Factsheet

August 2017 Factsheet

August 2017 Factsheet

July 2017 Factsheet

July 2017 Factsheet

June 2017 Factsheet

June 2017 Factsheet

May 2017 Factsheet

May 2017 Factsheet

April 2017 Factsheet

April 2017 Factsheet

March 2017 Factsheet

March 2017 Factsheet

February 2017 Factsheet

February 2017 Factsheet

January 2017 Factsheet

January 2017 Factsheet


2016 Factsheets

December 2016 Factsheet

December 2016 Factsheet

November 2016 Factsheet

November 2016 Factsheet

 
Key info
Key Info
Fund Launch Date1st November 2016
Legal StructureIrish Domiciled UCITS V Fund - ICAV
RegulatorCentral Bank of Ireland
Base CurrencySterling
Regional ExposureGlobal, primarily developed markets
BenchmarkThe fund is not benchmarked
Share Classes£ - A/I IE00BDC7CZ89 / IE00BD37NY30
$ - A/I IE00BD37NZ47 / IE00BDC7JY67
€ - A/I IE00BDC7CX65 / IE00BDC7CW58
Management Fee1% per annum
Performance Fee0%
DealingDaily
AdministratorSEI Investments – Global Fund Services
CustodianSEI Investments Trustee and Custodial Services (Ireland)
Auditors PriceWaterhouseCoopers
Legal CouncilMatheson
Firm ComplianceOptima Partners
Contact DetailsPatrick Valentine
patrick.valentine@latitudeim.com
+44 (0)207 087 9278
Documents
Fund Reports
Latitude 2018 Annual Review

Latitude 2018 Annual Review

Latitude 2017 Annual Review

Latitude 2017 Annual Review

Latitude Philosophy

Latitude Philosophy